The Competition Appellate Tribunal (CAT) has upheld the ‘s (CCP) finding that Reckitt Benckiser Pakistan Limited engaged in deceptive marketing practices. The company was found guilty of disseminating misleading information to consumers regarding the nature and character of its product, violating Section 10(2)(b) of the Competition Act, 2010.
The Tribunal ordered Reckitt Benckiser to pay a penalty of Rs30 million for its violation of the law. It also directed the company to fully comply with the corrective measures prescribed by the Commission within the stipulated timeframe.
Reckitt Benckiser had introduced changes to its product’s packaging and disclosures, including prominently displaying the disclaimer “Non-Medicated” in both English and Urdu on the front of the packaging and blister packs. The company is also required to publicize these changes through advertisements in widely circulated newspapers across Pakistan until full compliance is achieved.
The recovery of the penalty underscores CCP’s commitment to safeguarding consumer interests and ensuring businesses provide accurate, clear, and truthful information regarding their products and services.